|
|
|
市場調查報告書
中國的疫苗產業：2009年∼2010年
China Vaccine Industry Report, 2009-2010
|
中國的疫苗產業：2009年∼2010年 是由出版商ResearchInChina在2010年09月所出版的。
這份英文市場調查報告書包含111 Pages 價格從美金1900起跳。
本報告，調查中國的疫苗產業，分析整體疫苗產業、人類用以及動物用疫苗市場，提供市場規模、供需動向、競爭情勢以及市場預測等，並彙整市場區塊別的分析、進出口動向、主要疫苗廠商的檔案資料，由下列摘要形式闡述。
第1章 疫苗產業的概要
第2章 中國的疫苗產業
第3章 中國的人類用疫苗市場
- 現況
- 市場規模・業績量
- 需求・供給
- 競爭模式
- 銷售管道
- 動向
第4章 中國人類用疫苗市場的市場區塊
- B型肝炎疫苗
- 腦膜炎疫苗
- A型肝炎疫苗
- 流感疫苗
- 嗜血桿菌(Hib)疫苗
- 狂犬病疫苗
- 水痘疫苗
第5章 中國的動物用疫苗市場
- 現況
- 市場規模
- 需求・供給
- 市場競爭
- 市場區塊
- 發展因素
- 市場預測
第6章 中國的疫苗進出口：2009-2010年
第7章 中國的主要疫苗廠商
圖表
Abstract
Executive Summary
Being one of the world' s largest vaccine producers, China not only has many
vaccine companies, various vaccine categories and large quantity, but also the
human and animal vaccine enterprises are in general separated. At the end of
2009, there were around 38 human vaccine manufacturers and 54 animal vaccine
producers that had passed CMP certification in China. With the development of
national economy and the people' s growing awareness of precautionary measures,
Chinese vaccine market scale had increased continuously, with a CAGR of 21.5%
during 2007-2009. In addition, the vaccine market size of China reached
RMB15.2 billion in 2009, of which around RMB9 billion of human vaccine and
RMB6.2 billion or so of animal vaccine were included.
The vaccine industry is featured by high investment, high risk, long cycle and
high profit. In spite of somewhat drop in profit in recent years due to
increasingly intensive market competition, the overall profitability of the
vaccine industry is still kept at a relatively high level thanks to the lower
risk of disorderly competition as well as the restriction of barriers like
policy, technology and capital. In 2009, the gross margin of animal vaccine
industry was over 60%, and that of human vaccine industry was higher, above
70%.
In fact, the compulsory and free EPI vaccines are dominant in inoculation
vaccines in China on account of relatively low economic level and
comparatively lower awareness of epidemic precaution. Taking human vaccine
market for example, the release of EPI human vaccines reached 648.4261 million
person doses in 2009, accounting for 80.4% of the total; while the extra EPI
vaccine was only 158.512 million person doses, with a share of 19.6%. Yet, the
sum of EPI vaccine only occupied 38.9% of the total being restricted by
governmental procurement price, while the extra EPI vaccine covered 61.1%.
Focusing upon the overall vaccine market of China, the report also delves into
the development status quo, market scale, market demand & supply, competition
pattern, import & export, development prospect and relevant companies of human
vaccine and animal vaccine market segments.
Table of Contents
1. Overview of Vaccine Industry
- 1.1 Definition & Classification
- 1.2 Industry Chain
2. China Vaccine Industry
- 2.1 Overview
- 2.2 Operating Environment
- 2.2.1 International Market
- 2.2.2 Policy Environment
- 2.2.3 Biopharmaceutical Market in China
3. China Human Vaccine Market
- 3.1 Status Quo
- 3.2 Market Size & Gross Profit
- 3.3 Supply & Demand
- 3.4 Competition Pattern
- 3.5 Sales Channel
- 3.6 Dynamics
4. Human Vaccine Market Segments in China
- 4.1 Hepatitis B Vaccine
- 4.1.1 Supply & Demand
- 4.1.2 Competition Pattern
- 4.2 Meningococcal Vaccines
- 4.2.1 Supply & Demand
- 4.2.2 Competition Pattern
- 4.2.3 Market Forecast
- 4.3 Hepatitis A Vaccine
- 4.3.1 Supply & Demand
- 4.3.2 Competition Pattern
- 4.3.3 Market Forecast
- 4.4 Influenza Vaccine
- 4.4.1 Supply & Demand
- 4.4.2 Competition Pattern
- 4.5 Hib Vaccine
- 4.5.1 Supply & Demand
- 4.5.2 Market Forecast
- 4.6 Rabies Vaccine
- 4.6.1 Supply & Demand
- 4.6.2 Dynamics
- 4.6.3 Market Forecast
- 4.7 Varicella Vaccine
- 4.7.1 Supply & Demand
- 4.7.2 Competition Pattern
5. China Animal Vaccine Market
- 5.1 Status Quo
- 5.2 Market Scale
- 5.3 Supply & Demand
- 5.4 Market Competition
- 5.5 Market Segments
- 5.5.1 Swine Vaccines
- 5.5.2 Poultry Vaccines
- 5.5.3 Cattle & Sheep Vaccines
- 5.5.4 Pet Vaccines
- 5.6 Development Factors
- 5.7 Market Forecast
6. China' s Import and Export of Vaccines in 2009-2010
- 6.1 Human Vaccines
- 6.1.1 Import
- 6.1.2 Export
- 6.2 Animal Vaccines
- 6.2.1 Import
- 6.2.2 Export
7. Major Vaccine Manufacturers in China
- 7.1 China National Biotec Group
- 7.1.1 Beijing Tiantan Biological Products Co., Ltd
- 7.1.2 Shanghai Institute of Biological Products
- 7.2 Hualan Biological Engineering Inc.
- 7.2.1 Operation
- 7.2.2 Operation of Vaccine Business
- 7.2.3 Prospect of Vaccine Business
- 7.3 Liaoning Chengda Biotechnology Co., Ltd
- 7.3.1 Operation
- 7.3.2 Operation of Vaccine Business
- 7.3.3 Prospect of Vaccine Business
- 7.4 Chongqing Zhifei Biological Products Co., Ltd
- 7.4.1 Profile
- 7.4.2 Operation
- 7.4.3 Development Plan
- 7.5 Walvax Biotechnology Co., Ltd
- 7.5.1 Profile
- 7.5.2 Operation
- 7.5.3 Vaccine Projects
- 7.6 Sinovac Biotech Ltd.
- 7.6.1 Profile
- 7.6.2 Development
- 7.7 Changchun Changsheng Life Sciences Limited
- 7.8 Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd
- 7.9 Shenzhen Kangtai Biological Products Co. Ltd
- 7.10 Dalian Hissen Bio-Pharm Co., Ltd
- 7.11 Shenzhen Neptunus Bioengineering Co., Ltd
- 7.11.1 Operation
- 7.11.2 Vaccine Business & Development
- 7.12 Star Lake Bioscience
- 7.12.1 Operation
- 7.12.2 Vaccine Business & Development
- 7.13 China Animal Husbandry Industry Co., Ltd (CAHIC)
- 7.13.1 Profile
- 7.13.2 Operation
- 7.13.3 Status Quo of Animal Vaccine Business
- 7.13.4 Development Outlook of Animal Vaccine Business
- 7.14 Inner Mongolia Jinyu Group Co., Ltd
- 7.14.1 Profile
- 7.14.2 Operation
- 7.14.3 Status Quo of Animal Vaccine Business
- 7.14.4 Development Outlook of Animal Vaccine Business
- 7.15 Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd
- 7.15.1 Operation
- 7.15.2 Animal Vaccine Business
Selected Charts
- Classification of Vaccines
- Vaccine Industry Chain
- Market Scale: Human Vaccine vs Animal Vaccine, 2007-2009
- EPI Vaccine Varieties in China, 2010
- Global Sales Value and Growth: Human Vaccine vs Animal Vaccine, 2007-2009
- Sales Value of the Global Top 5 Vaccine Manufacturers, 2007-2009
- R &D of New Vaccines Worldwide, 2009-2010
- Main Mergers & Acquisitions in the Vaccine Industry Worldwide, 2005-2010
- Policies in Vaccine Industry
- Sales Value and Growth Rate of Biological & Biochemical Product Industry
in China, 2008-May 2010
- Major Human Vaccine Varieties and Producers in China
- The Release and Percentage (by Volume) of EPI and Extra EPI Vaccines in
China, 2007-2009
- The Release and Percentage (by Sum) of EPI and Extra EPI Vaccines in
China, 2007-2009
- China' s Human Vaccine Market Scale, 2006-2009
- Gross Margin of Major Human Vaccine Manufacturers in China, 2007-2009
- Market Supply and Demand of Some EPI Vaccines, 2009
- China' s EPI Human Vaccine Market Shares by Release, 2007-2009
- China' s Non-EPI Human Vaccine Market Shares by Release, 2007-2009
- Vaccine Distribution Channel in China
- R&D of New Human Vaccines in China as of H1 2010
- Release of “Recombinant Hepatitis B Vaccine” Manufacturers in
China, H1 2009 vs. H1 2010
- Manufactures that Obtained Certificate of “Recombinant Hepatitis B
Vaccine”, by Jun. 2010
- Release & Percentages of Hepatitis B Vaccine Manufacturers in China,
Jan.-Aug. 2010
- Sales Volume and Growth Rate of MPSV4 AC in China, 2006-2009
- Sales Revenue and Growth Rate of MPSV4 AC in China, 2006-2009
- Sales Volume and Growth Rate of MCV4 AC in China, 2006-2009
- Sales Revenue and Growth Rate of MCV4 AC in China, 2006-2009
- Sales Volume and Growth Rate of MPSV4 ACYW135 in China, 2008-2009
- Sales Revenue and Growth Rate of MPSV4 ACYW135 in China, 2008-2009
- Market Shares of MPSV4 ACYW135 Manufacturers in China, Jan.-Aug. 2010 (by
Release)
- Sales Volume Forecast of MPSV4 AC, Meningococcal Polysaccharide Conjugate
Vaccine AC and MPSV4 ACYW135 in China, 2010-2013
- Sales Revenue Forecast of MPSV4 AC, Meningococcal Polysaccharide Conjugate
Vaccine AC and MPSV4 ACYW135 in China, 2010-2013
- Capacity and Output of Hepatitis A Vaccine in China, 2006-2009
- Sales Volume and Growth Rate of Hepatitis A Vaccine in China, 2006-2009
- Sales Revenue and Growth Rate of Hepatitis A Vaccine in China, 2006-2009
- Sales Volume Forecast of Hepatitis A Vaccine in China, 2010-2013
- Sales Revenue Forecast of Hepatitis A Vaccine in China, 2010-2013
- Release Volume of Influenza Vaccine in China, 2009-H1 2010
- Market Shares of Split Influenza Virus Vaccine Manufacturers in China,
2009 (by Release)
- Shares of Chinese Subunit Influenza Vaccine Market, 2009 (by Release)
- Capacity and Output of Hib Vaccine in China, 2006-2009
- Sales Volume and Growth Rate of Hib Vaccine in China, 2006-2009
- Sales Revenue and Growth Rate of Hib Vaccine in China, 2006-2009
- Sales Volume and Growth Rate of Hib Vaccine in China, 2010-2013E
- Sales Revenue and Growth Rate of Hib Vaccine in China, 2010-2013E
- Sales Volume and Growth Rate of Human Rabies Vaccine in China, 2006-2009
- Sales Value and Growth Rate of Human Rabies Vaccine in China, 2006-2009
- Selling Price of Human Rabies Vaccine in China, 2006-2009
- Capacity and Output of Human Rabies Vaccine in China, 2006-2009
- Sales Volume Forecast of Human Rabies Vaccine in China, 2010-2013
- Sales Value Forecast of Human Rabies Vaccine in China, 2010-2013
- Main Manufacturers of Varicella Vaccine and Their Releases, 2009-Apr.2010
- Chinese Varicella Vaccine Market Shares, 2009 (by Release)
- China' s Animal Vaccine Market Share by Category, 2009
- China' s Animal Vaccine Industry Market Scale & Growth, 2006-2009
- Key Animal Vaccine Manufacturers in China
- Production of Main Chinese Animal Vaccine Manufacturers
- Consumption Structure of Animal Vaccines (by Animal Species) in China, 2009
- China' s Animal Vaccination Program, 2010
- Market Shares of Main Chinese Animal Vaccine Manufacturers by Sales, 2009
- Number of Leading Animal Vaccine Producers in Governmental Procurement,
2009
- China' s Swine Vaccine Market Scale, 2008-2009
- Performance Comparison of China' s Various Hog Cholera Vaccines
- Poultry Vaccine Market Scale in China, 2008-2009
- Ratio of China' s Poultry Vaccine by Category, 2009
- Cattle & Sheep Vaccine Market Scale, 2008-2009
- Foot and Mouth Disease in China, 2009
- Pet Vaccine Market Scale in China, 2008-2010
- Pet Vaccine Suppliers in China
- Stimulus for the Development of China' s Animal Vaccine Industry
- China' s Animal Vaccine Market Scale, 2010
- China' s Human Vaccine Import and Export Volume and Value, 2009-Jul. 2010
- China' s Human Vaccine Import Volume, 2009-Jul. 2010
- China' s Human Vaccine Import Value, 2009-Jul. 2010
- China' s Human Vaccine Import Volume and Value by Country, Jan.-Jul. 2010
- China' s Human Vaccine Export Volume, 2009-Jul. 2010
- China' s Human Vaccine Export Value, 2009-Jul. 2010
- China' s Human Vaccine Export Volume and Value by Country, Jan.-Jul. 2010
- China' s Animal Vaccine Import and Export Volume and Value, 2009-2010
- China' s Animal Vaccine Import Volume, 2009-2010
- China' s Animal Vaccine Import Value, 2009-2010
- China' s Animal Vaccine Import Volume and Value by Country, Jan.-Jul. 2010
- China' s Animal Vaccine Export Volume, 2009-2010
- China' s Animal Vaccine Export Value, 2009-2010
- China' s Animal Vaccine Export Volume and Value by Country, Jan.-Jul. 2010
- Operating Income and Total Profit of Beijing Tiantan Biological Products
Co., Ltd, 2006-2010
- Operating Income and Growth Rate of Beijing Tiantan Biological Products
Co., Ltd, 2007-2010
- Measles Vaccine Release and Market Shares of Beijing Tiantan Biological
Products Co., Ltd, 2008-2010
- Revenue and Profit of Shanghai Institute of Biological Products, 2007-2008
- Operating Income and Total Profit of Hualan Biological, 2007-2010
- Release and Percentage of Hualan Biological Vaccine Products, 2010
- Operating Income and Operating Margin of Hualan Biological Vaccine
Products, 2008-2010
- Operating Income and Total Profit of Liaoning Chengda, 2007-2010
- Vaccine Category and R&D Process of Liaoning Chengda
- Operating Income and Operating Margin of Vaccines of Liaoning Chengda,
2008-2010
- Sales Volume of Main Vaccines of Liaoning Chengda, 2009-2010
- Market Shares of Zhifei Biological Product Segments, 2007-2009
- Market Shares of EPI Vaccines of Zhifei Biological, 2007-2009
- Revenue and Profit of Zhifei Biological, 2007-2010
- Scheduling of the Researching Projects of Zhifei Biological, 2010-2012
- Vaccines on the Market and Capacity of Yunnan Walvax
- Revenue and Profit of Yunnan Walvax, 2007-2010
- Vaccine Projects of Yunnan Walvax
- Vaccine Development History of Sinovac Biotech Co., Ltd, 2001-2009
- Revenue of Sinovac Biotech Ltd by Product, 2008-2009
- Revenue and Profit of Changchuan Changsheng Life Sciences, 2007-2008
- Vaccines of Zhejiang Tianyuan Bio-Pharmaceutical
- Revenue and Profit of Zhejiang Tianyuan Bio-Pharmaceutical, 2008
- SKTB Revenue & Profit, 2007-2008
- Operating Income & Total Profit of Hissen Bio-pharm, 2007-2008
- Vaccine Projects of Hissen Bio-pharm
- Neptunus Operating Income & Total Profit, 2006-2010
- Neptunus Interlong Operating Income & Operating Profit, 2007-2010
- Star Lake Bioscience Operating Income & Total Profit, 2007-2010
- Operating Income, Total Profit, and Operating Margin of CAHIC, 2007-2010Q1
- Sales Volume of CAHIC Animal Vaccines, 2007-2009
- Percentages of CAHIC Vaccines, 2009
- Gross Profit of CAHIC Animal Vaccines, 2007-2009
- Operating Income and Total Profit of Inner Mongolia Jinyu Group, 2007-2010
- Operating Income and Operating Margin of Jinyu Animal Vaccines, 2007-2010
- Operating Income and Total Profit of Tecon, 2007-2010
- Operating Income and Operating Margin of Tecon Animal Vaccines, 2007-2010
|
 |
